Epizyme Inc

EPZM

Sector
Healthcare

Industry
Biotechnology

Website
epizyme.com




Buy / Sell (dollars)

1 Month

41.6% 41.6% Complete (success)
58.4% 58.4% Complete (danger)
$2.141M
avg. $2.141M
$3.003M
avg. $3.003M

Buy/Sell Ratio

0.713

Transactions

26

Filers

7

3 Month

41.6% 41.6% Complete (success)
58.4% 58.4% Complete (danger)
$2.141M
avg. $713,648.29
$3.003M
avg. $1.001M

Buy/Sell Ratio

0.713

Transactions

26

Filers

15

12 Month

93.6% 93.6% Complete (success)
6.4% 6.4% Complete (danger)
$52.202M
avg. $4.350M
$3.585M
avg. $298,783.12

Buy/Sell Ratio

14.56

Transactions

65

Filers

15

24 Month

90.8% 90.8% Complete (success)
9.2% 9.2% Complete (danger)
$55.984M
avg. $2.333M
$5.667M
avg. $236,106.30

Buy/Sell Ratio

9.88

Transactions

88

Filers

16

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers